(PharmaNewsWire.Com, November 25, 2021 ) This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
According to the new market research report “Cold Plasma Market by Industry (Textile, Electronics & Semiconductors, Polymer & Plastic, Food & Agriculture, Medical, Others), Application (Adhesion, Etching, Wound Healing), Regime (Atmospheric, Low pressure), & COVID-19 Impact – Global Forecast to 2025″, published by MarketsandMarkets™, the Cold Plasma Market is projected to reach USD 3.4 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 16.0% during the forecast period.
In the current regulatory climate-where the focus on sustainable techniques has risen—it is expected that the benefits of cold plasma will ensure its greater adoption in the years to come. Innovations in textile production and growing food safety concerns are the major factors driving the growth of this market.
The increasing prevalence of food-borne diseases, innovation in textile production, and the benefits of cold plasma in all industrial areas are the major factors driving the growth of this market.
By Textile Industry, the finishing segment is to dominate the cold plasma industry share in 2019
Based on industry, the cold plasma industry has been segmented into the textile industry, polymer & plastic industry, electronics & semiconductors industry, food & agriculture, and medical industry. Within the textile industry, the finishing segment accounted for the largest share in 2019. The large share of this segment can be attributed to the cost-effective and environmental-friendly cold plasma as compared to conventional treatments for textile finishing.
By Regime, the atmospheric cold plasma segment is expected to grow at the highest CAGR during the forecast period (2020-2025)
Based on the regime, the Cold Plasma Market has been segmented into atmospheric cold plasma and low-pressure cold plasma. The atmospheric cold plasma segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment is attributed to advantages offered by the atmospheric cold plasma, such as the easier handling of samples and scalability for in-line processing and integration into existing production lines.
Europe to hold the largest regional market share in 2019
Europe is expected to account for the largest share of the Cold Plasma Market in 2019, followed by North America. The large share of Europe in the global market can be attributed to the presence of a large number of cold plasma companies and growing R&D work in Germany.
The Asia Pacific region is expected to register the highest growth during the forecast period, primarily due to the growing demand for cold plasma technology in China, India, Japan, and South Korea, among other APAC countries. Considering this factor, a majority of global companies are focusing on developing and expanding their R&D capabilities and distribution networks in this region.
Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting
Browse Related Reports:
Plasma Fractionation Market by Product [IVIG, Albumin, Factor VIII, von Willebrand Factor, PCC, Protease Inhibitor], Application (Immunology, Hematology, Critical Care, Rheumatology) End User (Hospital, Clinic, Academic Institute)-Global Forecast to 2024
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’ flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: